The UK Paediatric Vaccine Group is taking part in a new study :
Chickenpox vaccine study in the second year of life
OKAH-193 (200147)
The study aims to test the safety of a vaccine that is designed to protect against chickenpox.
We aim to compare the Varilrix vaccine, which is already licensed in the UK, with another version of the same vaccine that is made in a different way in order to find out more about the safety and immune response of this new vaccine.
If your child is healthy, is aged between 12 and 23 months, and has not had chickenpox or the vaccine previously, please complete the short questionnaire below to see if you are eligible to take part.
Complete the questionaire